ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $48.7M

      Shares

      340k

      % of Portfolio

      3.64%

      Average Buy Price

      $179

      Avg closing price
      Price range

      23 Ensemble Capital Masimo Trades

      Ensemble Capital acquired 340k Masimo shares worth $48.7M. That's 3.64% of their equity portfolio (14th largest holding). The first Masimo trade was made in Q1 2019. Since then Ensemble Capital bought shares fifteen more times and sold shares on seven occasions. The investor's estimated purchase price is $60.9M, resulting in a loss of 20%.

      Avg closing price
      Price range
      Sold 16.4% shares (-66.7k shares) Q3 2024
      Avg closing price $116.03
      Price range $104.79 - $133.77
      Increased shares by 11.1% (+40.8k shares) Q2 2024
      Avg closing price $131.69
      Price range $115.24 - $144.91
      Sold 1.6% shares (-5.84k shares) Q1 2024
      Avg closing price $129.12
      Price range $109.17 - $146.85
      Increased shares by 1.1% (+4.14k shares) Q4 2023
      Avg closing price $93.21
      Price range $76.73 - $120.62
      Increased shares by 26.4% (+76.9k shares) Q3 2023
      Avg closing price $116.39
      Price range $84.17 - $161.17
      Sold 15.6% shares (-53.8k shares) Q2 2023
      Avg closing price $174.09
      Price range $155.24 - $196.47
      Increased shares by 5.9% (+19.2k shares) Q1 2023
      Avg closing price $168.70
      Price range $146.03 - $184.54
      Sold 5.0% shares (-17.2k shares) Q4 2022
      Avg closing price $137.60
      Price range $110.88 - $150.36
      Increased shares by 1.9% (+6.36k shares) Q3 2022
      Avg closing price $146.09
      Price range $125.58 - $169.38
      Increased shares by 0.7% (+2.42k shares) Q2 2022
      Avg closing price $133.79
      Price range $112.97 - $151.71
      Increased shares by 28.3% (+73.7k shares) Q1 2022
      Avg closing price $192.01
      Price range $135.71 - $284.87
      Sold 4.8% shares (-13k shares) Q4 2021
      Avg closing price $284.79
      Price range $266.41 - $303.29
      Sold 15.7% shares (-51k shares) Q3 2021
      Avg closing price $271.15
      Price range $249.00 - $285.24
      Increased shares by 48.3% (+106k shares) Q2 2021
      Avg closing price $228.17
      Price range $208.49 - $248.20
      Increased shares by 7.4% (+15k shares) Q1 2021
      Avg closing price $251.21
      Price range $220.31 - $283.75
      Sold 16.2% shares (-39.3k shares) Q4 2020
      Avg closing price $249.38
      Price range $223.82 - $271.35
      Increased shares by 24.2% (+47.3k shares) Q3 2020
      Avg closing price $224.17
      Price range $209.49 - $246.81
      Increased shares by 46.5% (+62.1k shares) Q2 2020
      Avg closing price $219.47
      Price range $178.49 - $250.39
      Increased shares by 0.1% (+72 shares) Q1 2020
      Avg closing price $171.51
      Price range $148.38 - $186.78
      Increased shares by 331.0% (+103k shares) Q4 2019
      Avg closing price $150.33
      Price range $140.81 - $159.49

      News about Masimo Corp and Ensemble Capital

      Masimo initiates legal action against activist investor Politan

      Masimo initiates legal action against activist investor Politan

      Medical device maker Masimo Corp on Tuesday said it has started litigation against Politan Capital in a California federal court, seeking to force the activi...

      reuters.com reuters.com, about 1 year ago
      Masimo Files Complaint Seeking Injunction Requiring Politan to Correct Material Misstatements

      Masimo Files Complaint Seeking Injunction Requiring Politan to Correct Material Misstatements

      IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (¡°Masimo¡± or the ¡°Company¡±) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and au...

      businesswire.com businesswire.com, about 1 year ago
      Leading Proxy Advisory Firm ISS Recommends Masimo Shareholders Vote FOR Both of Politan's Director Nominees

      Leading Proxy Advisory Firm ISS Recommends Masimo Shareholders Vote FOR Both of Politan's Director Nominees

      NEW YORK--(BUSINESS WIRE)--Politan Capital Management (together with its affiliates, ¡°Politan¡±), an 8.9% shareholder of Masimo Corporation (¡°Masimo¡± or the ¡°...

      businesswire.com businesswire.com, about 1 year ago
      Proxy advisor ISS says Masimo change is 'absolutely necessary' in brutal report

      Proxy advisor ISS says Masimo change is 'absolutely necessary' in brutal report

      Proxy advisor Institutional Shareholder Services said boardroom change at medical technology company Masimo was "absolutely necessary." The unusually sharp r...

      cnbc.com cnbc.com, about 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×